CytomX Therapeutics, Inc. (CTMX) stock
CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.94−0.05 (-2.27%)
Close on Nov 17, 2026Market cap $422.72MP/E –Yield –
CytomX Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CytomX Therapeutics's price to book ratio was 1.3× on Nov 11, 2026, against 4.7× a year earlier. Over the last 5 years it ranged from 1.3× to 21.3×, with a median of 5.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | −3.4 |
| 2025 | Dec 31, 2025 | 4.6× | −5.2 |
| 2022 | Jan 31, 2022 | 9.9× | +0.6 |
| 2021 | Dec 31, 2021 | 9.3× | +3.0 |
| 2020 | Dec 31, 2020 | 6.3× | +1.7 |
| 2019 | Dec 31, 2019 | 4.6× | +0.3 |
| 2018 | Dec 31, 2018 | 4.3× | −12.9 |
| 2017 | Dec 29, 2017 | 17.2× | +12.7 |
| 2016 | Dec 30, 2016 | 4.5× | – |
See a number that looks wrong?